| 000 | 01506 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250518071809.0 | ||
| 264 | 0 | _c20200924 | |
| 008 | 202009s 0 0 eng d | ||
| 022 | _a1471-2253 | ||
| 024 | 7 |
_a10.1186/s12871-019-0860-1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGu, Zhengfeng | |
| 245 | 0 | 0 |
_aDoxapram alleviates low SpO _h[electronic resource] |
| 260 |
_bBMC anesthesiology _c11 2019 |
||
| 300 |
_a216 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnesthetics, Intravenous _xadministration & dosage |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 |
_aDoxapram _xadministration & dosage |
| 650 | 0 | 4 |
_aEndoscopy, Gastrointestinal _xmethods |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFentanyl _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOxygen _xblood |
| 650 | 0 | 4 |
_aPropofol _xadministration & dosage |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aRespiratory System Agents _xadministration & dosage |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aXin, Lian | |
| 700 | 1 | _aWang, Haoxing | |
| 700 | 1 | _aHu, Chunxiao | |
| 700 | 1 | _aWang, Zhiping | |
| 700 | 1 | _aLu, Shunmei | |
| 700 | 1 | _aXu, Jingjing | |
| 700 | 1 | _aQian, Yiling | |
| 700 | 1 | _aWang, Jun | |
| 773 | 0 |
_tBMC anesthesiology _gvol. 19 _gno. 1 _gp. 216 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/s12871-019-0860-1 _zAvailable from publisher's website |
| 999 |
_c30342241 _d30342241 |
||